- Home
- CRNX vs MCHB Comparison
CRNX vs MCHB Comparison
Compare CRNX & MCHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- MCHB
- Stock Information
- Founded
- CRNX 2008
- MCHB 1905
- Country
- CRNX United States
- MCHB United States
- Employees
- CRNX N/A
- MCHB N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- MCHB Major Banks
- Sector
- CRNX Health Care
- MCHB Finance
- Exchange
- CRNX Nasdaq
- MCHB Nasdaq
- Market Cap
- CRNX 2.8B
- MCHB 3.0B
- IPO Year
- CRNX 2018
- MCHB N/A
- Fundamental
- Price
- CRNX $33.77
- MCHB N/A
- Analyst Decision
- CRNX Strong Buy
- MCHB
- Analyst Count
- CRNX 7
- MCHB 0
- Target Price
- CRNX $74.33
- MCHB N/A
- AVG Volume (30 Days)
- CRNX 1.1M
- MCHB 140.7K
- Earning Date
- CRNX 11-11-2025
- MCHB 11-08-2025
- Dividend Yield
- CRNX N/A
- MCHB N/A
- EPS Growth
- CRNX N/A
- MCHB N/A
- EPS
- CRNX N/A
- MCHB 0.88
- Revenue
- CRNX $1,392,000.00
- MCHB $597,455,147.00
- Revenue This Year
- CRNX $489.51
- MCHB N/A
- Revenue Next Year
- CRNX $661.93
- MCHB N/A
- P/E Ratio
- CRNX N/A
- MCHB $15.51
- Revenue Growth
- CRNX 0.51
- MCHB N/A
- 52 Week Low
- CRNX $24.10
- MCHB $12.52
- 52 Week High
- CRNX $62.53
- MCHB $43,478.00
- Technical
- Relative Strength Index (RSI)
- CRNX 56.44
- MCHB N/A
- Support Level
- CRNX $33.19
- MCHB N/A
- Resistance Level
- CRNX $37.23
- MCHB N/A
- Average True Range (ATR)
- CRNX 1.45
- MCHB 0.00
- MACD
- CRNX 0.11
- MCHB 0.00
- Stochastic Oscillator
- CRNX 52.12
- MCHB 0.00
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.